The firm earned recognition in four distinct institutional categories, including Hatch-Waxman Litigation Firm of the Year and Patent Strategy Firm of the Year. Its financial and corporate operations were also noted for mid-market transactions, alongside its work in product liability enforcement.
Four shareholders received individual nominations: Christopher C. Bolten for Patent Strategy in California, Scott J. Bornstein for Hatch-Waxman litigation, Lori G. Cohen for product liability, and Jonathan Wise for patent law in Pennsylvania. These accolades follow the publication’s methodology, which weighs market feedback and client testimony to identify leaders in the life sciences legal sector. Winners will be revealed on September 10.
Comments (0)
No comments yet. Be the first!